Results

Total Results: 1,636 records

Showing results for "treated".

  1. effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
  2. effectivehealthcare.ahrq.gov/products/infantile-hemangioma/consumer
  3. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - treatment sounds promising, but there are still questions about how frequently a patient would need to be treated
  4. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Of the 595 subjects, 173 subjects were treated in Phase 3 SBS studies (134/173 [77%] at the dose of … The most commonly reported (≥10%) adverse reactions in patients treated…across all clinical studies … After 24 weeks of treatment, 53.8% of patients treated with teduglutide reduced the number of infusion … days per week by 1 or more days, compared with 23.1% of patients treated with placebo experiencing … Anemia may be treated with vitamin B12, folic acid, and increased dietary iron.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
    January 01, 2011 - testing should be carried out annually in all patients with CKD and that such patients should be treated … regimen (i.e., repletion or continuous treatment)  Interactions between treatments (i.e., patients treated … with vs. without ESAs, patients treated with vs. without iron-replacement therapy)  Other factors … It is commonly seen among ESA-treated patients due to the inability of transferrin-bound iron to … The quality of life of hemodialysis recipients treated with recombinant human erythropoietin.
  6. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - with liraglutide 3 mg at 56 weeks was 8.0% compared to 2.6% for people treated with placebo. … At 56 weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer showed signs … of prediabetes, compared to 33% for the placebo-treated group. … Of the 39% of the people without prediabetes at randomisation, 7% of the liraglutide 3 mg treated … They were treated with metformin or a sulfonylurea drug or both.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - For patients with non–muscle-invasive bladder cancer treated with transurethral resection of bladder … In surveillance of patients treated for non–muscle-invasive bladder cancer, what is the effectiveness … For initial diagnosis or surveillance of patients treated for non–muscle-invasive bladder cancer, what … For patients with non– muscle-invasive bladder cancer treated with transurethral resection of bladder … For patients with non– muscle-invasive bladder cancer treated with transurethral resection of bladder
  8. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - with liraglutide 3 mg at 56 weeks was 8.0% compared to 2.6% for people treated with placebo. … At 56 weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer showed signs … of prediabetes, compared to 33% for the placebo-treated group. … Of the 39% of the people without prediabetes at randomisation, 7% of the liraglutide 3 mg treated … They were treated with metformin or a sulfonylurea drug or both.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - The median CRP of the treated patients was 12.0 (3.3-76.6).22 A study of tocilizumab found improvement … Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept. … Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with … The median CRP of the treated patients was 12.0 (3.3-76.6) Key Question 1b: Improve radiological … At the end of the 6 month withdrawal period (B) abatacept-treated subjects had greater improvements
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - The median CRP of the treated patients was 12.0 (3.3-76.6).22 A study of tocilizumab found improvement … Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept. … Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with … The median CRP of the treated patients was 12.0 (3.3-76.6) Key Question 1b: Improve radiological … At the end of the 6 month withdrawal period (B) abatacept-treated subjects had greater improvements
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - insufficient studies b This cohort study had a median of 364 days on treatment although whether patients were treated … Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated … treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated … Assessment of falls in older patients treated with duloxetine: a secondary analysis of a 24-week randomized
  12. Schwitzer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 - undergo  surgery:  “When you see the  people   around you falling apart, you sort of have to get treated … differently, and so do many other men who have been treated
  13. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
    October 01, 2014 - Only a fraction of treated patients respond within a week of starting any of the many medications available … patients might be associated with reduced societal costs and improved function and productivity of the treated … Department of Veterans Affairs, acute depressive episodes of bipolar disorder are treated with combinations … also sometimes considered.41 According to the National Institute of Mental Health, MDD is usually treated … How is depression diagnosed and treated? [internet].
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
    February 01, 2013 - (Which patients do equally well when treated nonoperatively or operatively?) … Feb patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2011;39(2):258-265. … (Which patients do equally well when treated nonoperatively or operatively?) … Clinicians need to know what is being treated before choosing or comparing treatments. … (Which patients do equally well when treated nonoperatively or operatively?)
  15. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - Authors reported the following:6,7 Patients treated with [Qsymia] had significant, sustained weight … with liraglutide 3 mg at 56 weeks was 8.0% compared to 2.6% for people treated with placebo. … At 56 weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer showed signs … of prediabetes, compared to 33% for the placebo-treated group. … They were treated with metformin or a sulfonylurea drug or both.
  16. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - forced expiratory volume in 1 second measurement that was 10.6 percentage points higher than patients treated … Patients treated with ivacaftor also demonstrated a significant improvement in quality of life (p<0.001 … By 48 weeks, patients treated with ivacaftor had gained significantly more weight and secreted significantly
  17. effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
    October 01, 2011 - If > 6 yrs old are always treated with drugs, say so. … Peer Reviewer #7 Results p 123 L-5 what does treated prevalence refer to? … As above Peer Reviewer #7 Results p 127 L-9 Does prevalence refer to treated (dx’d) prevalence? … Or extent to which it is treated? … Also, prevalence of medication use should be separate from treated diagnostic prevalence.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - How is it being used, and what is the evidence of benefits and harms for treated patients?
  19. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - systems could increase treatment rates and reduce health care burdens typically associated with poorly treated … or under-treated PTSD. … increases might be offset by reduced burdens associated with managing previously ineffectively treated … duty soldier with acute stress disorder, deployed at a remote combat outpost, who was successfully treated … A comparison of mental health diagnoses treated via interactive video and face to face in the Veterans
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - It is estimated that fewer than 1 in 10 people who are treated for AUD receive medications.† Expanding

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: